Sign in to view content

Evaluation of Baseline Characteristics on Lesion Progression in a Large Phase 2 Clinical Trial for Geographic Atrophy (FILLY Study)

Eleonora Lad, MD, PhD

Video
Published 2019

Eleonora Lad

AMD Non-neovascular Symposium

Related

Safety and Efficacy of SC Elamipretide to Treat Noncentral Geographic Atrophy: ReCLAIM-1 Results and Phase II ReCLAIM-2 Baseline Characteristics
David R Lally, MD
Annual Meeting Talks
2021
Subretinal Implantation of a Bioengineered Embryonic Stem Cell-Derived Retinal Pigment Epithelium Monolayer in Dry Age-Related
Amir H Kashani, MD PhD
Updates from the Field
2018
Preliminary Results from a First-in-human Phase I/II Gene Therapy Study (FOCUS) of Subretinally Delivered GT005, an Investigational AAV2 Vector, in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration
Jared S. Nielsen, MD, MBA
Updates from the Field
2022

Category: AMD-Non-neovascular

See more